Scientists say they've found how Alzheimer's spreads through the brain, identifying a common brain protein called Arc that appears to ferry toxic Tau from damaged neurons into healthy ones.
The discovery, published in the journal Cell, points researchers toward a new way to think about slowing the disease: instead of trying to eliminate Tau entirely, future treatments could aim to stop it from reaching healthy brain cells in the first place.
What researchers discovered about Tau and Arc
Alzheimer's disease is marked by the buildup of Tau, a protein that damages and eventually kills brain cells. As Tau spreads into new regions of the brain, patients experience worsening memory loss and cognitive decline.
A team led by Jason Shepherd, a professor of neurobiology at University of Utah Health, compared mouse models of Alzheimer's with and without a protein called Arc, which normally helps neurons communicate with one another. Mice lacking Arc showed dramatically less Tau transfer between brain cells — in Shepherd's words, the spread was "almost gone."
How Arc helps toxic Tau travel between neurons
Under normal conditions, Arc packages itself inside tiny membrane-bound sacs called extracellular vesicles, which shuttle between neurons carrying cellular signals. The research team found that toxic Tau exploits this same delivery system, attaching itself to Arc so it can hitch a ride out of a diseased neuron and into a healthy one.
Every neuron contains some Tau, but in Alzheimer's disease the protein clumps into sticky tangles that block a cell's internal transport system before eventually killing it. Mitali Tyagi, first author of the study and now a postdoctoral researcher at Washington University in St. Louis, described these tangles as "glue monsters" that can break into smaller fragments, called Tau seeds, capable of corrupting healthy Tau once they reach a new neuron.
In the Alzheimer's mouse model, the researchers detected extracellular vesicles carrying both Arc and clumped Tau, and these vesicles were able to enter healthy cells and trigger new tangles. When Arc was removed from the mice, those same vesicles contained very little Tau, and the disease no longer spread efficiently between neighboring cells.
Why the Arc-Tau link matters for future treatment
The findings complicate a simple "block Arc" strategy, because the protein also plays a protective role early in the disease. By helping neurons expel excess toxic Tau, Arc allows damaged cells to survive longer; without it, Tau becomes trapped inside neurons and accumulates to toxic levels, killing those cells faster.
That trade-off suggests the more promising target isn't Arc itself, but the journey the Tau-carrying vesicles take between cells. Researchers say intercepting these vesicles after they leave a diseased neuron — but before they reach a healthy one — could slow or prevent further spread of Alzheimer's disease, even if it wouldn't reverse damage that has already occurred.
Notably, the team also found extracellular vesicles containing both Arc and Tau in human brain tissue, suggesting the same mechanism may be at work in people, not just mice. Still, Shepherd cautions that the work remains in an early stage: "We're far away from saying that we're developing a treatment for anything. But it could open new avenues to get to that point."
What's next for Alzheimer's research
The study, "Arc mediates intercellular tau transmission via extracellular vesicles," was funded in part by the National Institutes of Health, the Alzheimer's Association, and the Chan-Zuckerberg Initiative, among other supporters. Follow-up work will need to confirm the mechanism in human tissue and test whether blocking these specific vesicles is safe and effective — a process likely to take years before it could influence patient care. For readers tracking the science behind neurodegenerative disease, this discovery adds to a growing body of brain health research aimed at slowing cognitive decline before symptoms take hold, and it sits alongside other recent science breakthroughs reshaping how researchers think about disease spread at the cellular level.
Frequently asked questions
Does this mean there's a new Alzheimer's treatment available now?
No. The research was conducted in mice and human tissue samples, not in clinical trials, so any therapy based on this discovery is still years away.
What is Arc, and why does it matter?
Arc is a protein neurons normally use to communicate via extracellular vesicles. Researchers found that toxic Tau hijacks this same delivery system to spread between brain cells in Alzheimer's disease.
